ARCHIVES

Glaxo, Mass General Begin Phase III Trial Of Tykerb

This article is from The Cancer Letter archive.

Vol. 29 No. 12 | December 29, 2006

Download PDF Visit The Full Archive

Related Articles

NIH “RFA Game” Defeats Purpose Of OAM, Advisor Says

September 30, 1994

Cancer Mortality Rate Down 1.3 Percent, ACS Report Finds

July 30, 2010

NCI CTEP-Approved Trials For the Month of December

December 26, 2014

More money would speed progress, NCI says, but backs off previous commitment to meet 2015 goal by 2010.

July 29, 2005

Mammary Cell/Hormone Report Abstracts From BCTF Meeting

January 16, 1976

NCI Advisory Group, Other Cancer Meetings

May 29, 1987